Progressive Glioblastoma
Progressive Glioblastoma is an aggressive type of brain cancer that can worsen over time, often leading to severe neurological symptoms. It is characterized by rapid growth and a tendency to invade surrounding brain tissue.
We are studying whether the medication Perampanel can help reduce tumor growth in patients with progressive glioblastoma before surgery. This trial also looks at quality of life and cognitive function to see how the treatment affects patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Progressive Glioblastoma is an aggressive type of brain cancer that can worsen over time, often leading to severe neurological symptoms. It is characterized by rapid growth and a tendency to invade surrounding brain tissue.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.